📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Olaris

1.1 - Company Overview

Olaris Logo

Olaris

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of metabolomics and machine learning-based disease diagnosis and treatment solutions, including Olaris CEREBRO for metabolite profiling to identify individual molecular profiles, myOLARIS diagnostics, a suite of in vitro diagnostic products to optimize patient-specific treatments and outcomes, and Biomarkers of Response (BoRs) technology to determine which patients will benefit from specific therapies and reduce adverse events.

Products and services

  • Biomarkers of Response (BoRs): Predictive technology that identifies biomarkers to determine which patients will benefit from specific therapies, optimizing outcomes and reducing adverse events
  • MyOLARIS™ diagnostics: Modular in vitro diagnostic products developed using metabolomics and machine learning to optimize treatments and outcomes for individual patients
  • Olaris CEREBRO: Profiling-based platform that uses metabolite profiling and machine learning algorithms to identify individual molecular profiles for improved diagnosis and treatment of diseases

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Olaris

Exact Imaging Logo

Exact Imaging

HQ: Canada Website
  • Description: Provider of 29 MHz micro-ultrasound imaging for real-time targeted prostate biopsies via the ExactVu system, offering high-resolution visualization and enhancements like ExactVu Micro Doppler. Solutions include PRI-MUS protocol for prostate cancer risk assessment, FusionVu for MRI-ultrasound alignment and targeting, and Cognitive Assist for cognitive fusion displaying MRI-identified lesions in real time.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Exact Imaging company profile →
Novelos Therapeutics Logo

Novelos Therapeutics

HQ: United States Website
  • Description: Provider of biopharmaceutical research, development, and commercialization focused on oxidized glutathione.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Novelos Therapeutics company profile →
Tesaro Logo

Tesaro

HQ: United States Website
  • Description: Provider of oncology-focused biopharmaceutical solutions dedicated to improving the lives of cancer patients, leveraging management expertise to identify, acquire and develop promising drug candidates and to commercialize safer, more effective cancer therapies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tesaro company profile →
PharmaMar Logo

PharmaMar

HQ: Spain Website
  • Description: Provider of oncology medicines inspired by the sea, discovering antitumor molecules from marine organisms through integrated research and development. Delivers innovative products to equip healthcare professionals with new tools to treat cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full PharmaMar company profile →
IONIQ Sciences Logo

IONIQ Sciences

HQ: United States Website
  • Description: Provider of solutions for early detection of multiple cancers to improve survivability and reduce healthcare costs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full IONIQ Sciences company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Olaris

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Olaris

2.2 - Growth funds investing in similar companies to Olaris

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Olaris

4.2 - Public trading comparable groups for Olaris

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Olaris

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Olaris

What does Olaris do?

Olaris is a provider of metabolomics and machine learning-based disease diagnosis and treatment solutions, including Olaris CEREBRO for metabolite profiling to identify individual molecular profiles, myOLARIS diagnostics, a suite of in vitro diagnostic products to optimize patient-specific treatments and outcomes, and Biomarkers of Response (BoRs) technology to determine which patients will benefit from specific therapies and reduce adverse events.

Who are Olaris's competitors?

Olaris's competitors and similar companies include Exact Imaging, Novelos Therapeutics, Tesaro, PharmaMar, and IONIQ Sciences.

Where is Olaris headquartered?

Olaris is headquartered in United States.

How many employees does Olaris have?

Olaris has 1,000 employees 🔒.

When was Olaris founded?

Olaris was founded in 2010 🔒.

What sector and industry vertical is Olaris in?

Olaris is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Olaris

Who are the top strategic acquirers in Olaris's sector and industry

Top strategic M&A buyers and acquirers in Olaris's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Olaris?

Top strategic M&A buyers groups and sectors for Olaris include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Olaris's sector and industry vertical

Which are the top PE firms investing in Olaris's sector and industry vertical?

Top PE firms investing in Olaris's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Olaris's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Olaris's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Olaris's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Olaris include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Olaris's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Olaris?

The key public trading comparables and valuation benchmarks for Olaris include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Olaris for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Olaris with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Olaris's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Olaris with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Olaris's' sector and industry vertical?

Access recent funding rounds and capital raises in Olaris's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Olaris

Launch login modal Launch register modal